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Abstract
Background: The ZNF706 gene encodes a protein that belongs to the zinc finger family of proteins and was found
to be highly expressed in laryngeal cancer, making the structure and function of ZNF706 worthy of investigation.
In this study, we expressed and purified recombinant human ZNF706 that was suitable for structural analysis in
Escherichia coli BL21(DH3).
Findings: ZNF706 mRNA was extracted from a larynx tissue sample, and cDNA was ligated into a cloning vector
using the TOPO method. ZNF706 protein was expressed according to the E. coli expression system procedures and
was purified using a nickel-affinity column. The structural qualities of recombinant ZNF706 and quantification alpha,
beta sheet, and other structures were obtained by spectroscopy of circular dichroism. ZNF706's structural modeling
showed that it is composed of α-helices (28.3%), β-strands (19.4%), and turns (20.9%), in agreement with the
spectral data from the dichroism analysis.
Conclusions: We used circular dichroism and molecular modeling to examine the structure of ZNF706. The results
suggest that human recombinant ZNF706 keeps its secondary structures and is appropriate for functional and
structural studies. The method of expressing ZNF706 protein used in this study can be used to direct various
functional and structural studies that will contribute to the understanding of its function as well as its relationship
with other biological molecules and its putative role in carcinogenesis.
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Background
The ZNF706 gene encodes a protein that belongs to the
zinc finger family of proteins. Zinc finger proteins are in-
volving in endogenous gene expression control by binding
to specific DNA sequences [1]. Zinc finger-containing tran-
scriptional factors have previously been shown to partici-
pate in the MAPK signaling pathway regulation. These
factors are among the principal methods of gene expression
regulation on eukaryotic cells [2]. Moreover, the ZNF706
gene was associated with the Epidermal Growth Factor
(EGF) to control the cell volume via the ICln gene [3]. ZNF
proteins are now known to have additional activities such
as the recognition of RNA and other proteins [4].
Despite the little information available about the bio-
logical functions of ZNF genes [5], some were indicated
as participant in diseases or gene expression control.
The transcriptional activity of activator protein 1 (AP1)
was found to be enhanced by the ZNF445 gene [6]. The
ZNF674, ZNF41 and its homologous ZNF81 are three X
chromosome ZNF genes located in Xp11 and were asso-
ciated with non-specific X-linked mental retardation
[7,8]. The ZNF743 protein was found to be associated
with methyl-CpG-binding protein 2 (MBD2) and was
implicated in transcriptional and epigenetic controls [7].
The ZNF706 gene, which is located at 8q22.3, is a zinc
finger gene family member. Currently, there are no studies
that describe the more specific functions of this gene. How-
ever, it was observed that ZNF706 gene has a sex-specific
gene expression pattern in human lymphoblastoid cell lines
[8], and was found to be highly expressed in laryngeal
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cancer [9]. Likewise, copy number amplifications on
chromosome 8 in cancer gastric samples were identified
[10]. The gained regions detected in at least 25% of the
samples were located at 8p11-q24 [10]. In addition, the
ZNF706 gene was concordantly up-regulation in the ana-
lyzed gastric cancer samples [10]. High expression of the
ZNF133 gene was also verified in head and neck cancer
[11]. However, low expression of other zinc finger family
members, such as ZNF185 [12,13], ZNF212 [14], ZNF262
[14] and ZNF273 [15] has already been observed in head
and neck cancer. Thus, the zinc finger family genes can
operate as enhancers or repressors of gene expression;
depending on their action, they may have high or low
expression levels in neoplastic tissues.
Structurally, the zinc finger proteins can be classified
from the number and type of amino acids associated in
zinc ion binding site, like the C2H2, C2HC, C4 ribbon,
C4 GATA, C6, C8, C3HC4 ring finger and H2C2. The
C2H2-type zinc finger proteins (of which ZNF706 is a
member) have the most common DNA binding site and
correspond to approximately 30% of all transcription
factors in the human genome [16,17]. The C2H2-type
zinc fingers fold into a ββα structure with the support of
the zinc ion. Each finger typically recognizes 3–4 base
pairs of DNA [17].
ZNF706 protein has 76 amino acids; however, no in-
formation on ZNF706 protein structure and function is
available in the literature. In this work, we expressed,
using a eukaryotic system, and purified the recombinant
human ZNF706 human protein for structural analysis by
molecular modeling and circular dichroism. Structural
characterization may aid the study of the specific inter-
actions of ZNF706 with other biological molecules such
as inhibitors. This will contribute to the understanding
of the specific function of ZNF706 and its putative role
in carcinogenesis and to the design of new drugs.
Results
ZNF706 mRNA was extracted from a larynx tissue sam-
ple and cDNA was ligated into a cloning vector using
the TOPO method (Invitrogen, Grand Island, NY,
USA). Amplification of ZNF706 cDNA produced a frag-
ment of approximately 262 bp (Figure 1A). After the
cloning of this PCR product into the pET101 expression
vector, five clones were verified using specific primers
from the TOPO kit (Invitrogen, Grand Island, NY,
USA). The PCR product was approximately 262 bp long
(Figure 1B). Sequencing verified the identity of the se-
quence and the fidelity of cloning in clones 1 and 3
(data not shown).
Selected clones were transformed into E. coli BL21
(DE3) competent cells and the protein expression was
performed using the T7 system after induction with
IPTG 1.5 mM IPTG (Sigma, St. Louis, MO, USA) for 16
hours.
The SDS-PAGE electrophoresis showed the ZNF706
protein expression in a soluble fraction with a molecular
weight of 12 kDa as determined by Coomassie Brilliant
reagent (BIO-RAD, Hercules, CA, USA) (Figure 2). The
protein was purified on a nickel-resin column (BIO-
RAD, Hercules, CA, USA), and the fractions of ZNF706
protein could be visualized (Figure 3). ZNF706 protein
has 76 amino acids and is 8.49 kDa in size. However,
because the heterologous protein has a 6xHis tag and
one start codon, the observed size is 12 kDa.
After purification, the ZNF706 protein fractions were
concentrated using an Amicon ultrafiltration cell system
(MWC 3,000 Da) (Millipore, Billerica, MA, USA)
(Figure 4). The ZNF706 concentration (3.0 mg) was
obtained using the absorbance reading at 280 nm.
The secondary structure content of ZNF706 was veri-
fied by CD spectroscopy (Figure 5). The CD spectrum
showed that the protein contained a higher quantity of
α-helical structures with a minimum ellipticity at 205
nm and at 222 nm. The secondary structure indicated
by CDPro suite of the CD spectrum [18] shows that the
protein is composed of α-helices (35%), β-strands (10%),
turns (27%) and random coils (28%). The results
obtained are in agreement with the expected structure
for zinc finger proteins.
Figure 1 Amplification of ZNF706 gene. A) Agarose gel shows RT-PCR of the ZNF706 gene. Lane M: molecular weight marker (Invitrogen,
Grand Island, NY, USA); Lane 1: amplification of ZNF706 gene (262 bp). B) Agarose gel shows amplification of the ZNF706 gene cloned into
pET101 expression vector in 5 plasmid preparations.
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The sequence alignment between HsZNF706 and the
zinc-finger region of human Zinc- Fingers and Homeo-
boxes 1 (ZHX1) (PDB code 2GHF) showed 34.1% iden-
tity, with 41 amino acids aligned. HsZNF706 has 76
amino acid residues in the sequence, and the 2GHF
template has 102 residues. Nine residues from the N-
terminus of the target were removed. The structure ge-
nerated by homology modeling [19,20] had an RMSD
of 1.095 compared to the template; this estimate takes
into account the Cα from the 65 superimposed resi-
dues (Figure 6). The global stereochemical quality [21]
of the HsZNF706 protein model indicated that 98.3%
of the amino acids were in the most allowed and add-
itional allowed regions, with only 1.7% (Lys55) in the
disallowed region. Structural analysis showed that the
side chain of Lys55 is in contact with the solvent in a
superficial conformation. The Procheck software [21]
was used to calculate the G-factor average value and
set to be -0.1. The Verify-3D [22] software analysis, re-
vealed that 32.4% of the amino acids had an average
value 3D- 1D score of >0.2, showing some compatibi-
lity with the HsZNF706 model. Fifty percent of the
amino acids in the template had an average value 3D-1D
score of >0.2.
The HsZNF706 model consists of α-helices (28.3%),
β-strands (19.4%) and turns (20.9%), compared to 25.8%,
16.1% and 20.4%, respectively, for the template. The
structure is dominated by metal-ligand, heme and/or
disulfide bridges, like other members of this small protein
class, and is arranged in a β-β-α zinc finger fold. This
model includes a simple fold consisting of the N-terminal
β-hairpin and C-terminal α-helical region; each part
provides two zinc-coordinating residues. Using the par-
tial structural model of HsZNF706, the binding sites of
the zinc ion were determined (Figure 7). The first ion is
near the N-terminal β-hairpin in a site formed mainly
Figure 2 Polyacrylamide gel SDS-PAGE 15% shows ZNF706
protein expression. Lane M: molecular weight marker (PageRuler™
Prestained Protein Ladder - Fisher Scientific, Pittsburgh PA, USA);
Lanes 1: no induction; Lane 2: 16 hours of induction with 1,5 mM IPTG.
Figure 3 Polyacrylamide gel SDS-PAGE 15% shows ZNF706
protein after purification and concentration procedures. Line M:
molecular weight marker (PageRuler™ Prestained Protein Ladder -
Fisher Scientific, Pittsburgh PA, USA); Line 1: ZNF706 protein.
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by neutral and hydrophobic residues, and the second
ion is near the second β-hairpin and C-terminal α-helix
(Figure 7) at 2.9 Angstroms from the Q56 side chain
and 2.7 Angstroms from the E70 side chain.
The generated model presents two cysteine residues
next to each other in the tridimensional conformation
(Cys41 and Cys44), but not involved in a disulfide bridge
due to the distance between them (the distances of two
bonded sulfur atoms is known to be distributed between
1.8 - 2.0 Å with a highest frequency at about 2.0 Å in
proteins, and the distance between the sulfur atoms in
the model is more than 3 Å). The model has a conserved
folding module in ZNFs, which is the most probable
folding obtained. The crystallographic structure will con-
firm these data. The N-terminal 9 residues of the target
were not considered in this prediction because they are
not reflected in the template and can be considered a
characteristic region of HsZNF706.
Discussion
Zinc finger (ZNF) proteins play critical roles in cell
growth, proliferation, apoptosis, and intracellular signal
transduction [23]. The ZNF706 gene cDNA is 2755 bp
in length and encodes a putative protein of 76 amino
acid residues. However, the function and structure of the
ZNF706 protein were uncharacterized. The results
presented here show that recombinant ZNF706 gene
was cloned and the protein was expressed in E. coli bac-
teria cell line and purified from the soluble fraction in a
single procedure step.
In this work, we used circular dichroism and molecu-
lar modeling to examining the structure of ZNF706. Cir-
cular dichroism (CD) spectroscopy is an important
methodology used in structural biology for quantifying
secondary structure content, conformational changes
due to drug binding, folding, interactions involving pro-
tein molecules and protein quality [24]. Our results sug-
gest that human recombinant ZNF706 keeps its
secondary structures and is able to perform functional
and structural studies. The agreement between the sec-
ondary structures predicted by molecular modeling and
the secondary structure obtained by (CD) spectroscopy
increases our confidence in the accuracy of the ZNF706
model. However, the N-terminal region of ZNF706 pro-
tein could not be resolved because there is no suitable
template deposited in public databases. This region may
be unique to the ZNF706 protein and therefore needs to
be resolved. This problem reinforces the need for
Figure 4 Polyacrylamide gel SDS-PAGE 18% shows purification
of the recombinant human ZNF706 protein by nickel-affinity
chromatography. Lane M: molecular weight marker (PageRuler™
Unstained Protein Ladder - Fisher Scientific, Pittsburgh PA, USA);
Lane 1: crude extract. Lane 2: insoluble fraction. Lane 3: soluble
fraction. Lane 4: Column washed with buffer plus imidazole 10 mM.
Lane 5. Column washed with buffer plus imidazole 20 mM. Lanes
6-7. ZNF706 protein elution with buffer plus imidazole 250 mM.
Lane 8: ZNF706 protein elution with buffer plus imidazole 500 mM.
Figure 5 Analysis of ZNF706 secondary structure by CD spectroscopy. The CD spectrum of ZNF706 was acquired in 300 mM sodium
phosphate, pH 8.0, at a concentration of 3,0 mg/ml.
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experimental structural studies involving techniques
such as crystallography to solve the structure of the
N-terminal region of this protein. Moreover, experi-
mental determination of the three-dimensional structure
will contribute to investigations of interactions of
ZNF706 with ligands.
The knowledge of the Human ZNF706 protein struc-
ture is important for understanding the mechanisms of
its interactions with other molecules and allowing
structure-aided drug design [25,26]. The interaction
between DNA target sequence and the zinc-finger proteins
motivated the design of specific zinc finger peptides that
can be used for medical and biochemical interaction studies
[27,28].
An example of the application of these custom zinc finger
proteins involves several kinds of methyltransferases, which
have been linked to zinc-finger motifs and analyzed in vitro
and in vivo conditions. This targeted DNA methylation al-
lows artificial gene silencing and can be used to prevent an
overexpressed gene in cancer by adding a methyl group to
the target gene. Targeted DNA methylation was demon-
strated to be effective at repressing Herpes Simples Virus
type I (HSV-1) infection in cell culture [29]. Several groups
have tested zinc fingers to inhibit the replication of inte-
grated HIV [30,31] and high-risk HPV type 18, which is in-
volved in cervical cancer [32]. Thus, custom zinc finger
proteins can be engineered to control the expressions of
target genes and have therapeutic potential for the study
and treatment of diseases. Moreover, with further advances
in zinc finger protein research, it may become possible to
construct synthetic cell networks and control high-level
vital functions [17].
The ZNF706 protein structural data obtained in this
work by circular dichroism and molecular modeling can
contribute to the understanding of the protein’s func-
tion, the relationships to other biological molecules and
its possible role in carcinogenesis. Moreover, it repre-
sents the first step towards a future customized ZNF706
peptide that could act on cellular signaling networks and
establishes the relationship between ZNF706 and dis-
eases such as cancer.
Conclusion
In this work, we used circular dichroism and molecular
modeling to examine the structure of ZNF706. Our re-
sults suggest that recombinant human ZNF706 keeps its
secondary structure and is appropriate for functional
and structural studies. The agreement between the sec-
ondary structures predicted by molecular modeling and
the secondary structure obtained by (CD) spectroscopy
increases our confidence in the accuracy of the ZNF706
model. The data obtained in this work can contribute to
the understanding of the protein’s function, relationships
to other biological molecules and its possible role in
carcinogenesis allowing structure-aided drug design.
Moreover, it represents the first step towards a future
customized ZNF706 peptide that could act on cellular
signaling networks and establishing the relationship be-
tween ZNF706 and diseases such as cancer.
Methods
Reverse transcription reaction and ZNF706 cDNA cloning
For the Reverse Transcription (RT-PCR) procedure, total
RNA was extracted from larynx tumor tissue samples
using Trizol reagent (Invitrogen). The full-length
ZNF706 cDNA was performed using the following
Figure 7 Secondary structure elements from HsZNF706
showing the zinc binding sites.
Figure 6 Superposition of main chain of HsZNF706 model (light
gray) and 2GHF structure (dark gray).
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oligonucleotide primers: Forward, CATCACCATCA
GATGGCTCGTGGACAG; Adapt F, CACCATGAA
ACATCATCACCATCACCATCAG and Reverse, TT
ATGCCTGAACATCAGCTA, which were constructed
using the GenBank ZNF706 cDNA sequence No.
NM_016096.3 as the reference. The N-terminal
polyhistidine tag used for recombinant protein purifica-
tion is shown in bold. The protease recognition site for
removal of the N-terminal polyhistidine tag is shown in
italics. The nucleotides CACC are the overhang se-
quence for binding to pET101 (Invitrogen).
The ZNF706 cDNA (231 bp) was amplified using the
constructed set of primers and standard PCR conditions
with Elongase (Invitrogen). After checking the amplifica-
tion on an agarose gel, nested PCR with the product
from the first PCR and Adapt F and Reverse primers
was performed using the same amplification conditions.
The amplification products were checked on an agarose
gel and consisted of a specific band of approximately
262 bp, corresponding to the expected size of the
ZNF706 gene (231 bp) plus the 31 bp of the Adapt F
primer.
Subcloning in E. coli TOP10
After purification with the Qiagen Purification Kit, the
amplified fragment was inserted into the pET101 expres-
sion vector following the Championg pET Directional
TOPO Expression Kit manufacturer’s instructions
(Invitrogen). pET101::ZNF706 was transformed into E.
coli DH5alpha competent cells. Several colonies were
collected from Luria-Bertani (LB) plates supplemented
with ampicillin (50 μg/ml) and then inoculated into 5 ml
of LB medium containing ampicillin (50 μg/ml). The cul-
ture was incubated for 16 hours at 37°C. Recombinant
plasmid was extracted with a PureLink plasmid mini
prep kit (Invitrogen). The fidelity of the cloned product
was verified by sequencing using the specific primers
provided in the TOPO kit.
ZNF706 protein expression
The expression plasmids pET101::znf706 were transformed
into E. coli BL21(DE3) competent cells. After selection on
LB agar plates (ampicillin - 50 μg/mL), recombinant co-
lonies were inoculated into 5 mL of LB medium
supplemented with ampicillin (50 μg/mL). To test the opti-
mal condition for ZNF706 protein expression, E. coli BL21
(DE3) cells carrying pET101::znf706 were grown in the
presence of IPTG (isopropyl β-D-thiogalactoside) at dif-
ferent concentrations: 1.5mM, 1.0mM, 0.75mM and
0.5mM. After centrifugation, the cells were re-suspended
in lysis buffer containing 100 mM NaCl, 10mM Tris and
50mM NaH2PO4, at pH 8.0) and disrupted by sonication
(eight short bursts of 15 s). The proteins were separated by
SDS-PAGE electrophoresis and the bands were visualized
using Coomassie Blue reagent.
Large scale expression and purification
A total of 20 mL of LB cell culture containing the re-
combinant plasmid was diluted in 2 L of LB
supplemented with ampicillin (50 μg/mL). The culture
was incubated at 37°C and 240 rpm until the cells
achieve OD600 = 0.6. At this point, the ZNF706 expres-
sion was induced with 1.5 mM of IPTG following incu-
bation at 37°C for 16 hours. The culture cell was
submitted to centrifugation and the harvested cells were
re-suspended in 20 mL of lysis buffer (100 mM NaCl, 10
mM Tris and 50 mM NaH2PO4, pH 8.0). To lyse the
cells, the samples were incubated on ice with lysozyme
(0.5 mg/mL) for 30 min. After sonication (eight short
bursts, with 15 s) the lysate was submitted to centrifuga-
tion for 30 min at 14,000 rpm and 4°C. The supernatant
was loaded onto a nickel-affinity column (BIO-RAD;
Profinity™ IMAC Ni-Charged Resin; 4 mL) pre-
equilibrated with purification buffer containing 50 mM
NaH2PO4 and 300 mM NaCl, at pH 8.0. After washing,
bound proteins were eluted with an imidazol gradient
(20 mM, 50 mM, 250 mM and 500 mM imidazol in
purification buffer). Fractions containing ZNF706 were
pooled, concentrated and dialyzed using an Amicon
ultrafiltration cell (MWC 3,000 Da). The protein was
analyzed by SDS-PAGE electrophoresis and visualized
using Coomassie Brilliant Blue reagent.
The recombinant ZNF706 quantification was obtained
by direct absorbance readings at 280 nm.
Circular dichroism
Circular dichroism (CD) spectroscopy was realized in a
Jasco 710 spectropolarimeter at 25°C. The CD spectra
was measured with a protein concentration of 3.0 mg/
mL in phosphate buffer pH 8.0, (300 mM), using a 0.05
mm optical length. The spectra were collected from 195
to 255 nm. The results were converted to mg/ml ellipti-
city units, [Φ] (deg cm2 decagram-1), and the alpha,
beta sheet, and other structures were verified using
CDPro software package [18].
Molecular modeling
The program MODELLER 9v8 was used to model the
HsZNF706 structure. This program is an automated ap-
proach for homology or comparative modeling by satis-
faction of spatial restraints [19,20]. The molecular
modeling methodology began with the alignment of the
target protein to be determined (HsZNF706) with the
templates (related known three-dimensional protein
structures). The template was a human Zinc fingers and
homeoboxes protein 1 (ZHX1) (PDB code 2GHF) solved
by Nuclear Magnetic Resonance (NMR), which has
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34.1% identity and an overlap of 41 amino acids with the
HsZNF706 sequence. The alignment among the amino
acid sequence was the input of the software and a three-
dimensional model of the target protein sequence was
the output. The energy terms and spatial restraints en-
forcing proper stereochemistry [33] were combined into
an objective function. The resulting ZNF protein models
were generated by optimization of the objective function
in a Cartesian coordinate system. The optimization was
performed with the variable target function method [34]
by employing method of conjugate gradients and simu-
lated annealing. A total of 300 models were obtained,
and the final model was selected based on the stereo-
chemical quality.
The overall stereochemical quality of the HsZNF706
model was based on the following analyses: 1) a
Ramachadram plot obtained using the program
PROCHECK [21], 2) the rmsd from the distance of se-
condary structure alignment calculated using PDBeFold
[http://www.ebi.ac.uk/msd-srv/ssm/], 3) the G-factor
value calculated for the torsion angles (phi-psi, chi1-chi2,
chi-1, chi-3, chi-4 and omega values for each amino acid
residue) and covalent geometry (for the main-chain bond
lengths and bond angles; calculated using PROCHECK)
[21] and 4) the compatibility of the protein model with
its sequence, calculated using Verify -3D software and a
three-dimensional profile [22].
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